Ocular Therapeutix (OCUL) announced that Namrata Saroj, OD, has joined the Company on a full-time basis as Chief Business Officer, CBO. Dr. Saroj previously served as Development Strategy Consultant to Ocular since February 2024.
Don't Miss our Black Friday Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OCUL:
- OCUL Upcoming Earnings Report: What to Expect?
- Disney initiated, Cisco upgraded: Wall Street’s top analyst calls
- Ocular Therapeutix initiated with an Outperform at Scotiabank
- Ocular Therapeutix management to meet with Piper Sandler
- Ocular announces accelerated timelines for SOL-1 registrational trial